Skip to main content
ABINGDON HEALTH PLC logo

ABINGDON HEALTH PLC — Investor Relations & Filings

Ticker · ABDX ISIN · GB00BLF79J41 LEI · 213800XFI4WV3FBILO20 IL Manufacturing
Open in API
Filings indexed 261 across all filing types
Latest filing 2022-12-19 Share Issue/Capital Cha…
Country GB United Kingdom
Listing IL ABDX

About ABINGDON HEALTH PLC

https://www.abingdonhealth.com/

Abingdon Health PLC is a contract development and manufacturing organization (CDMO) that specializes in lateral flow assays, also known as rapid tests. The company provides a comprehensive, fully integrated service to a global customer base, supporting diagnostic projects from initial concept and development through to high-volume automated manufacturing and regulatory support. Its services cater to a wide range of sectors, including clinical, animal health, environmental, and plant health. Abingdon Health also develops and manufactures lateral flow readers and smartphone reader applications, which complement its assay services by enabling digital data capture and analysis.

Recent filings

Filing Released Lang Actions
Award of Options under new LTIP Scheme
Share Issue/Capital Change Classification · 99% confidence The document is an announcement from Abingdon Health PLC, dated December 19, 2022, detailing the 'Award of Options under new LTIP Scheme' to directors and senior management. It explicitly lists the number of options awarded to Persons Discharging Managerial Responsibilities (PDMRs) and includes detailed transaction tables typical of insider dealing or share scheme disclosures. This type of filing, reporting personal share transactions (specifically option awards) by directors, falls under the category of Director's Dealing (DIRS). Although it involves shares, it is not a general share issue (SHA) or a buyback (POS), but a specific disclosure about executive compensation/insider activity.
2022-12-19 English
AGM Statement
AGM Information Classification · 98% confidence The document explicitly states it is an "AGM Statement" delivered by the CEO at the company's Annual General Meeting (AGM). The content discusses the company's performance relative to the preliminary results announced previously and provides an update on the outlook and cash position, which is typical content for an address given at an AGM. Although it is distributed via RNS (Regulatory News Service), the core subject matter is the AGM proceedings. Therefore, the most specific classification is AGM Information (AGM-R). The document length (4828 chars) is substantial enough that it is not merely an announcement of the meeting, but the content delivered at the meeting itself.
2022-12-19 English
Group of companies' accounts made up to 2022-06-30
Regulatory Filings
2022-12-05 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1937 characters) and contains the header 'RNS Number : 4946H' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific, non-standard regulatory announcement concerning market operations rather than a core financial report (like 10-K, IR, or ER). Since it is a specific regulatory announcement that doesn't fit the other defined categories (like DIRS, DIV, or CAP), the most appropriate classification is the general regulatory filing fallback category, RNS.
2022-11-24 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1920 characters) and its primary content is an announcement regarding a 'Price Monitoring Extension' for a security on the London Stock Exchange, identified by the 'RNS Number : 4888H'. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This structure—a brief notification about a market event or administrative update provided via the RNS system—fits the definition of a general regulatory announcement that doesn't correspond to a specific financial report (like 10-K, IR, or ER). Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for miscellaneous regulatory announcements.
2022-11-24 English
Preliminary Results
Earnings Release Classification · 100% confidence The document explicitly states it announces the 'preliminary results for the year ended 30 June 2022' and provides detailed financial highlights (Revenue, EBITDA loss, Loss for the period, Cash position) and operational highlights for that fiscal year. This content structure is characteristic of an Annual Report or a comprehensive report covering a full fiscal year. However, the filing is presented as an RNS announcement (RNS Number : 4276H) and contains the phrase 'announces its preliminary results'. While it covers the full year, the term 'preliminary results' often suggests a summary preceding the final audited 10-K filing, or it could be the primary annual disclosure if the company is not required to file a 10-K. Given the comprehensive nature covering the entire fiscal year (Year Ended 30 June 2022) and the inclusion of detailed financial figures, it is most closely aligned with an Annual Report (10-K) or a comprehensive Annual Report (AR) if it's not the formal 10-K filing. Since it is a full-year result announcement via RNS, and it contains detailed financial performance metrics, it is classified as an Annual Report (10-K) or the closest equivalent comprehensive annual disclosure. If it were just a short announcement linking to the full report, it would be RPA/RNS, but this text contains the core results summary. Given the options, 10-K is the standard for full-year results, but AR covers standalone audit reports/results. Since this is the *preliminary* result announcement for the *full year*, and it's presented as a regulatory news service (RNS) release, the most accurate classification for the *content type* (full-year results) is 10-K, but the *delivery mechanism* suggests ER or RNS. Since it is a full-year report summary, and not just quarterly highlights (ER), and it's not just an announcement of a report (RPA), 10-K is the best fit for the content, even if delivered via RNS. However, if we strictly follow the 'MENU VS MEAL' rule, this is an announcement *of* the results, not the full statutory filing itself. But the content is too detailed for a simple RPA. Let's re-evaluate: It is a full-year result announcement. If it were a quarterly result, it would be ER. Since it is annual, it is closest to 10-K content. Since it is delivered via RNS and is titled 'Preliminary Results', it functions as the primary annual disclosure document released to the market, which often substitutes for the 10-K in non-US contexts or precedes it. Given the depth, I will classify it as 10-K, representing the full-year financial disclosure. FY 2022
2022-11-24 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.